Atlas Trials

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

Clinical trial NCT00882726 · COMPLETED

Trial details

NCT number
NCT00882726
Sponsor
Centocor, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2009-02-01
Primary completion
2010-04-01
Enrollment
133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.